Press Releases Avacta Group Plc

Equities

AVCT

GB00BYYW9G87

Market Closed - London S.E. Other stock markets 11:35:07 2024-06-06 am EDT			5-day change	1st Jan Change
41.25 ^GBX	+0.61%		-3.84%	-64.51%

May. 23	Windward wins deal; Kodal progresses at Bougouni	AN
May. 23	Avacta Group plc Announces Successful Completion of First Cohort and Dosing of Three Patients of the Second Cohort in Arm 2 of Avacta's Ava6000 Phase 1 Trial	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Avacta : Targeting the Tumor Microenvironment – June 2024 presentation deck	Jun. 03	PU
Avacta : Annual Report and Accounts 2023	May. 31	PU
Avacta : AGM Notice – 2024	May. 31	PU
Avacta Group plc - Christina Coughlin, MD, PhD, appointed Chief Executive Officer of Avacta Group	May. 01	AQ
Avacta : Results for the Year Ended 31 December 2023	Apr. 30	PU
Avacta : Preliminary Results for the Year Ended 31 December 2023	Apr. 30	PU
Avacta : Christina Coughlin, MD, PhD, appointed Chief Executive Officer of Avacta Group	Apr. 30	PU
Avacta : R&D Spotlight series – Episode 2	Apr. 25	PU
Avacta Group plc - Block Listing Application to AIM	Apr. 24	AQ
Avacta Group plc - Notice of Results	Apr. 24	AQ
Avacta Therapeutics Reports Data from the Ongoing Phase 1 Clinical Trial of AVA6000 at the AACR Annual Meeting Demonstrating Clinical Proof-of-Concept Showing Multiple Patient Responses	Apr. 10	AQ
Avacta Group - AVA6000 Abstract Release by AACR and Full Presentation Update	Apr. 05	GL
Avacta : Glossary	Apr. 05	PU
Avacta : Research and Development Spotlight Series – Episode 1	Mar. 27	PU
Avacta Group - Updated Results from Single-Agent Phase 1 Clinical Trial of Peptide Drug Conjugate, AVA6000 to be presented in a Poster at the American Association of Cancer Research Annual Meeting on April 9, 2024	Mar. 07	AQ
Updated Results from Single-Agent Phase 1 Clinical Trial of Peptide Drug Conjugate, AVA6000 to be Presented in a Poster at the American Association of Cancer Research (AACR) Annual Meeting on April 9, 2024	Mar. 05	AQ
Avacta Group plc - Appointment of Chief Business Officer	Dec. 20	AQ
Appointment of Chief Business Officer	Dec. 19	AQ
Avacta : ALS-6000-101 Phase 1a Three-Weekly Dose Escalation Safety Study Data	Dec. 13	PU
Avacta Group plc - Block Listing Application to AIM	23-10-19	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Avacta Group Plc

Equities

AVCT

GB00BYYW9G87

Press Releases

Filters